Contract Services Clinical Research
Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database. Thyrosco...
November 19, 2026 | News
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...
November 19, 2026 | News
Delonix Bioworks, a clinical-stage biotechnology company pioneering next-generation outer membrane vesicle (OMV) vaccines, today announced that it has ente...
November 18, 2026 | News
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental ...
November 18, 2026 | News
The opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is Innovent's first European regulatory...
November 17, 2026 | News
Phase 3 trial evaluates the safety and efficacy of an investigational once-daily formulation of trientine tetrahydrochloride compared to D-penicillamine ...
November 17, 2026 | News
iMed-6.0 brings multimodal reasoning to medical imaging and powers a multi-task CT model, while zero-code tools support specialty AI development. DIAGENS ...
November 16, 2026 | News
Accelerating the Development of an AI-Driven Ecosystem for Innovative Drug R&D and Translation Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") rece...
November 11, 2026 | News
SINTBILO® (tafolecimab injection) monotherapy achieved significant reduction of LDL-C level, with > 60% mean LDL-C reduction after 12 weeks ...
November 10, 2026 | News
33% investigator-assessed objective response rate and 90% disease control rate at 10 mg/kg every three weeks in patients with PD-(L)1-resistant/refrac...
November 09, 2026 | News
Akeso, Inc. announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or metastatic biliary tract cancer...
November 06, 2026 | News
Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation...
November 06, 2026 | News
Extended collaboration will accelerate research and development in advanced connectivity and emerging 5G Advanced & future 6G tec...
November 05, 2026 | News
InventisBio Co., Ltd. announced that its JH2 selective TYK2 inhibitor nomelcitinib (D-2570) has met both the primary endpoint and the key s...
November 04, 2026 | News
Most Read
Bio Jobs
News